Clinical Trials Browser

Phase 2 × Testicular Neoplasms × durvalumab × Clear all

NCT03081923 2021-05-14

APACHE

Phase 2 Terminated

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms